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Abstract
Bacterial artificial chromosomes (BACs) are well-established cloning vehicles for functional genomics and for constructing
targeting vectors and infectious viral DNA clones. Red-recombination-based mutagenesis techniques have enabled the
manipulation of BACs in Escherichia coli without any remaining operational sequences. Here, we describe that the F-factor-
derived vector sequences can be inserted into a novel position and seamlessly removed from the present location of the
BAC-cloned DNA via synchronous Red-recombination in E. coli in an en passant mutagenesis-based procedure. Using this
technique, the mini-F elements of a cloned infectious varicella zoster virus (VZV) genome were specifically transposed into
novel positions distributed over the viral DNA to generate six different BAC variants. In comparison to the other constructs,
a BAC variant with mini-F sequences directly inserted into the junction of the genomic termini resulted in highly efficient
viral DNA replication-mediated spontaneous vector excision upon virus reconstitution in transfected VZV-permissive
eukaryotic cells. Moreover, the derived vector-free recombinant progeny exhibited virtually indistinguishable genome
properties and replication kinetics to the wild-type virus. Thus, a sequence-independent, efficient, and easy-to-apply mini-F
vector transposition procedure eliminates the last hurdle to perform virtually any kind of imaginable targeted BAC
modifications in E. coli. The herpesviral terminal genomic junction was identified as an optimal mini-F vector integration site
for the construction of an infectious BAC, which allows the rapid generation of mutant virus without any unwanted
secondary genome alterations. The novel mini-F transposition technique can be a valuable tool to optimize, repair or
restructure other established BACs as well and may facilitate the development of gene therapy or vaccine vectors.
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Introduction
Bacterial artificial chromosomes (BACs) are low-copy F-factor
derived replicon units and well-established vectors to clone large
DNA molecules in E. coli [1,2]. Regulatory elements of the mini-F
replicon strictly maintain a BAC in one or maximally two copies per
bacterial cell, reducing the potential for inter- and intramolecular
homologous recombination between repeated sequences. Mini-F
replicons can provide the stable propagation of complex DNA
moleculesupto300 kbinrecombination-deficientE. colistrains[1,2].
Consequently, BACs are widely used in sequencing projects and
functional genomics of diverse organisms, and for the construction of
targeting vectors and infectious viral DNA clones [2–8]. However,
the chimeric constitution of prokaryotic and eukaryotic sequences in
addition to the current localization of the mini-F vector within the
cloned DNA limits the versatility of an established BAC clone.
In the recent years, a number of recombination-based
mutagenesis techniques have been introduced for rapidly manip-
ulating large BAC-cloned DNA fragments in E. coli without
leaving behind any operational elements [9–12]. Two-step en
passant mutagenesis is a versatile and highly efficient markerless
BAC manipulation technique, combining Red recombination with
the cleavage by the homing endonuclease I-SceI [11,13,14]. In this
procedure, large primers are designed to generate a PCR product
for the insertion by Red recombination of a selection marker
together with an I-SceI recognition site flanked by a 50 bp direct
sequence duplication of the cloned DNA into the target sequence.
Upon selection of recombinants, a double-strand break can be
initiated at the I-SceI site to seamlessly excise the positive selection
marker by a second Red-mediated recombination via the short
duplicated sequences. Using appropriate plasmids and bacterial
strains, en passant mutagenesis can be applied to rapidly and
seamlessly generate point mutations or deletions and to insert large
functional sequences [11,15].
In order to facilitate the generation of mutant virus progeny, the
large viral genomes of numerous herpesviruses and of some other
viruses have been constructed in the past years as infectious BACs
[16–22]. Full-length viral DNA can be maintained and seamlessly
manipulated in E. coli and subsequently delivered into virus-
permissive cells to allow the reconstitution of mutant progeny that
will represent a uniform and homogenous virus population [16].
To investigate the neurotropic human a-herpesvirus varicella
zoster virus (VZV), the causative agent of chickenpox and shingles
[23], we previously constructed the 125 kb linear DNA genome
of the European VZV wild-type strain HJO as infectious BAC
(Schmidt M, and Fickenscher H, in preparation) [24–26].
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effective approach to get insight into herpesvirus biology and is
predicted to facilitate the development of therapeutic gene and
vaccine vectors [3,8]. To prevent interference of the mini-F
elements with the viral functions, herpesvirus BACs are usually
engineered in a way that the vector sequences can be removed
upon virus reconstitution by site-specific recombinases, such as
Cre, which leave behind only one residual small recognition site
[27]. Complete removal of the bacterial elements during the virus
reconstitution from an infectious BAC has been established by
homologous recombination of engineered large genomic duplica-
tions [28,29]. However, this strategy can be associated with
illegitimate recombination events during the bacterial or viral
DNA replication or it’s efficiency can highly depend on the vector
insertion site within the viral genome.
In this study, we demonstrate a novel technique based on en
passant mutagenesis to seamlessly transpose the mini-F sequences
within BAC-cloned DNA in E. coli. We developed this method to
rapidly identify an optimal integration site for the mini-F sequences
within the cloned genome of the VZV strain HJO, to induce their
efficient and seamless excision from the viral DNA upon virus
reconstitution in VZV-permissive cells. The insertion of the mini-F
sequences directly between the VZV genomic termini resulted in a
BAC variant of which the vector elements were rapidly released
during the viral DNA replication even without additional opera-
tional sequences such as loxP sites or genomic duplications.
Results
Red-Recombination-Mediated Mini-F Vector
Transposition
For the targeted and seamless transposition of the mini-F
sequences of BAC-cloned DNA in E. coli, a second mini-F vector
had to be inserted into a different position while removing the pre-
existing mini-F cassette by two events of recombination. Since
maximally two copies of a BAC can exist per bacterial cell [1,2], we
assumed that these reactions must be induced synchronously to
prevent the uneven segregation or disruption of putative interme-
diates with two mini-F replicons during the strictly coordinated
chromosomal-like proliferation upon bacterial cell division. There-
fore,wedevelopedanovelproceduretoinducethetargetedinsertion
of an additional mini-F vector into a novel position of the cloned
DNA by a first Red recombination [14], simultaneously with the
seamless removal of the primary mini-F cassette by an en passant
mutagenesis-mediated second Red recombination [11,15].
The original HJO BAC, termed pHJO, consists of the full-
length VZV genome, which is organized into a unique long (UL)
and a unique short (US) region, flanked by very small (RL) or large
inverted (RS) repeats, respectively [30], and pBeloBAC11 vector
elements within the unique AvrII site of the US region (Fig. 1A). In
the first step of the en passant mutagenesis, pHJO was prepared for
the mini-F sequence transposition reaction as follows (Fig. 1B).
First, the kanamycin resistance gene aphAI and the homing
Figure 1. Mini-F vector transposition. A) The infectious BAC pHJO. In the pHJO BAC clone the mini-F sequences are located within the unique
AvrII site of the VZV US region. RL: repeat of the long region; UL: unique region long; RS: repeat of the short region; US: unique region short. B)
Preparation of the BAC for the mini-F transposition. An aphAI-I-SceI cassette (blue) was amplified with primers bearing specific 50 bp extensions
(green and black). One primer provides a 50 bp duplication (red). The generated PCR product was applied to replace the cat gene of the pBeloBAC11
vector sequences (green) from pHJO, resulting in pHJOFep. C) Synchronous mini-F transposition reaction. A mini-F transfer construct was used to
insert a second pBeloBAC11 vector via Red-mediated recombination of flanking 0.7 kb homologous sequences (orange and yellow) into the target
position of interest. After introduction of a double-strand break by I-SceI expression, the primary mini-F cassette was seamlessly excised by a second
Red-mediated recombination of the short 50 bp duplication, resulting in a pHJO variant.
doi:10.1371/journal.pone.0008178.g001
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(Fig. 1B, blue elements) were amplified with primers bearing short
extensions. One primer contained at the 59 terminus 50 bp that
were homologous to sequences at the border of the chloramphen-
icol resistance gene cat and the mini-F replicon of the pBeloBAC11
vector (Fig. 1B, green extension). The other primer consisted at the
59 terminus of 50 bp that were homologous to HJO sequences
directly adjacent to the cat gene of the pBeloBAC11 vector in
pHJO (Fig. 1B, black extension). The latter primer provided also a
50 bp duplication homologous to viral sequences found adjacent
to the mini-F replicon at the opposite pBeloBAC11 vector end in
pHJO (Fig. 1B, red extension). Subsequently, the resulting PCR
product was used to substitute the cat gene at one pBeloBAC11
vector end of pHJO via Red recombination by the aphAI-I-SceI
cassette and the 50 bp homologous to viral sequence at the
opposite vector end. The resulting BAC, termed pHJOFep,
contained an aphAI-I-SceI-associated mini-F replicon flanked by
a 50 bp direct viral sequence duplication (Fig. 1B). Consequently,
pHJOFep was ready for the insertion of a second pBeloBAC11
vector into a target position of interest by Red recombination and
selection for chloramphenicol resistance, and for the seamless
excision of the aphAI-I-SceI-mini-F cassette by the second en passant
mutagenesis step.
For the insertion of the pBeloBAC11 vector into the target
position of interest a mini-F transfer constructs was generated using
the plasmid pCeu2 [29]. This transfer construct consisted of a
6.4 kb modified pBeloBAC11 vector without cos and loxP sequences
flanked by 0.7 kb viral sequences homologous to regions located at
either site of the target position of interest (Fig. 1B and 1C, orange
and yellow elements). The transfer construct was engineered within
the multiple cloning site (MCS) between the two I-CeuI homing
endonuclease restriction sites of plasmid pCeu2. To additionally
avoid the degradation of the BAC in the following transposition
procedure, the pBeloBAC11 vector elements were engineered in
inverse orientation between the viral sequences with respect to the
present mini-F fragment of pHJOFep (Fig. 1B and 1C).
In the mini-F sequence transposition reaction, the pBeloBAC11
vector was inserted into the target position of interest using the
prepared transfer construct and the aphAI-I-SceI-mini-F cassette
was excised via two successively induced Red recombinations
(Fig. 1C). First, the mini-F transfer construct was released from the
pCeu2 vector backbone and used to insert the 6.4 kb pBeloBAC11
derivate via Red-mediated recombination of the 0.7 kb flanking
homologous viral sequences into the target position of interest in
pHJOFep (Fig. 1C). Immediately after that, a double-strand break
was introduced between the aphAI gene and the 50 bp duplication
by I-sceI expression and the aphAI-mini-F cassette was seamlessly
removed in the second en passant step by Red-mediated recombi-
nation of the short 50 bp duplication (Fig. 1C). To maintain the
cloned HJO genome during this transposition reaction, the Red-
mediated pBeloBAC11 insertion, the I-SceI-mediated double-
strand break introduction, and the Red-mediated aphAI-mini-F
fragment excision was induced in a novel synchronous reaction (for
detailed protocol see Materials and Methods). The resulting BAC
variant of pHJO with pBeloBAC11 vector in the target position of
interest comprised a repaired unique AvrII site of the VZV US
region (Fig. 1C).
Versatility and Efficiency of the Mini-F Vector
Transposition
Using corresponding mini-F transfer constructs, the pBelo-
BAC11 elements were transposed from the unique AvrII site of the
VZV US region within the BAC-cloned HJO genome into ORF22,
ORF50,o rORF54 of the UL region, into either the coding domain
of the duplicated ORF62/71 of the large S repeats, or directly
between the genomic termini. The resulting BACs were termed
pHJOF22, pHJOF50, or pHJOF54 (Fig. S1 and S2), and
pHJOF62, pHJOF71, or pHJOFpac (Fig. 2 and S2), respectively.
Potential BAC recombinants with transposed pBeloBAC11
sequences were first identified by colony-PCR screening for
determination of the mini-F excision from the unique AvrII site of
the US region (Table 1).
Figure 2. Infectious BAC clones with genome-intrinsic releasable mini-F sequences. Scheme of the generation of pHJO variants with mini-
F sequences (green) releasable by intrinsic genome replication processes. Upon mini-F transposition in E. coli, the vector sequences were shifted
within the BAC-cloned HJO genome (pHJO) from the unique AvrII site of the US region (reverse with respect to UL, regarding the defined VZV
prototype genome organization) into ORF62, ORF71, or directly into genomic terminal junction of VZV, to generate pHJOF62, pHJOF71, or pHJOFpac,
respectively. Virus reconstitution from the pHJO variants yielded vector-free progeny rHJO-F
-.
doi:10.1371/journal.pone.0008178.g002
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tested colonies were positive by PCR screening for the mini-F
sequence removal from the unique US AvrII site. Eight of the
positive clones were tested by restriction fragment length polymor-
phism(RFLP) andPCR analysis, and thepBeloBAC11transposition
was confirmed in all these BACs. Six of the RFLP pattern-positive
BACs were investigated via sequencing. The seamless repair of the
unique AvrII site was confirmed in all BAC clones (Table 1). When
transposing the pBeloBAC11 sequences into the terminal genomic
junction, only 9 of 168 tested colonies were positive for the vector
excision from the US AvrII site by PCR screening. In 3 of those 9
BACs the pBeloBAC11 transposition into the terminal genomic
junction was confirmed by RFLP and PCR. The correct RFLP
pattern was analyzed via sequencing, confirming the precise
insertion of the pBeloBAC11 vector between the VZV DNA ends
and the seamless repair of the US unique AvrII site (Table 1).
In conclusion, the pBeloBAC11 sequences were successfully
transposed into specific target positions distributed over the unique
or repeat regions of the VZV genome, to generate six different
BAC variants of pHJO. Since the mini-F vector transposition into
ORF22 was less effective than into ORF50 or ORF54 (Table 1), the
efficiency of the reaction seemed to decrease the more distant the
target position of interest is located from the primary mini-F
insertion site. It appeared also, that the mini-F transposition into
positions of the unique regions is more efficient than into the
repeated regions of the VZV genome. However, potential BAC
candidates with transposed mini-F sequences, independently from
in which position they were moved within the cloned VZV
genome, can be rapidly identified via colony-PCR screening.
Efficient Genome-Intrinsic Mini-F Vector Self-Excision
from the VZV DNA Ends
In the nucleus of an infected cell, herpesviral DNA circularizes
and replicates into branched and linear concatemeric molecules of
serially and covalently linked genomic units [31,32]. The
concatemeric genome multimers are cleaved precisely at the
junctions of the genomic termini by a terminase complex and the
derived linear monomers are packed by a head-full sensing
mechanism into preformed nascent particles [33,34]. During DNA
replication, sequence inversions or deletions can be mediated by
inter- and intramolecular homologous recombination of inversely
or directly repeated elements [35–37].
The pBeloBAC11 sequences were inserted into ORF22, ORF50,
or ORF54 to generate BAC variants comprising self-excisable
vector elements with inverse genomic duplications in genes which
are putatively essential or important for the virus propagation in
vitro, but not for the viral DNA replication (Fig. S1; pHJOF22-DX,
pHJOF50-DX, or pHJOF54-DX) [38–40]. This should induce the
immediate vector elimination upon repair of the gene function by
two events of homologous recombination of the genomic
duplication as described previously [29]. Upon virus reconstitution
from the three pHJO-DX variants in VZV-permissive MeWo
melanoma cells, the vector sequences were seamlessly released
from the viral DNA during four rounds of virus propagation
(Table 1). However, in comparison to the virus reconstitution from
the original pHJO BAC, the virus reconstitution from the pHJO-
DX variants occurred only after one further cell passage of the
transfected MeWo cells.
The single deletion of the duplicated ORF62/71 of the large
VZV S repeats was shown to lead to efficient repair of the
disrupted repeat region by homologous recombination events with
the intact repeat region [41]. Furthermore, it was surmised that
the genomic termini are formed to some degree independently by
two precise cleavages of a terminase complex [42–44]. In addition,
sequences at the genomic termini were believed to be recombi-
national hot-spots due to the induction of an additional double-
strand break mechanism or due to the high GC content at the
DNA ends [35–37]. Therefore, we assumed that mini-F sequences
inserted into one of the coding domains (ORF62 or ORF71) of the
immediate-early transactivator IE62 or into the terminal genomic
junction can be rapidly released by intrinsic DNA replication or
genome maturation processes, even without a genomic duplica-
tion. For this reason, we transposed the mini-F sequences into
ORF62, ORF71 or directly between the VZV DNA ends, to
generate pHJOF62, pHJOF71 or pHJOFpac, respectively (Fig. 2).
These BACs could stably be propagated in E. coli, since
unexpected rearrangements in comparison to the mini-F excision
construct pHJOFep and the original pHJO BAC were not detected
by RFLP analysis (Fig. S2).
Table 1. Efficiency of the mini-F vector transposition in E. coli and the vector self-excision upon virus reconstitution.
Efficiency of the mini-F transposition and the mini-F self-excision
target bacteria positive/tested virus passage viruses positive/tested
mini-F excision
a mini-F transposition
b mini-F detection
d mini-F excision
f
Colony-PCR RFLP sequencing PCR (experiments) PCR sequencing
ORF22 3/23 2/3 2/2
c 4 (6) 6/6 2/2
ORF50 15/23 8/8 6/6
c 4 (4) 4/4 2/2
ORF54 15/23 8/8 6/6
c 4 (1) 1/1 1/1
ORF62 5/96 2/5 2/2 4; .7
e (2) 1/2
e 1/1
ORF71 8/96 2/8 2/2 5; 6 (2) 2/2 2/2
Junction 9/168 3/9 1/1 2 (8) 8/8 16/16
aColony-PCR screening for determination of the mini-F excision from the US unique AvrII site.
bConfirmation of the mini-F transposition into the given target site by RFLP and PCR or sequencing analysis.
cOnly the repair of the unique AvrII site was investigated via sequencing.
dAverage number of the last virus passage in which the mini-F sequences were detected by PCR after virus reconstitution. Numbers of the performed independent
transfection experiments are given in brackets.
eDetection of mini-F until passage 7 and beyond.
fConfirmation of the mini-F excision in derived virus progenies by PCR or sequencing.
doi:10.1371/journal.pone.0008178.t001
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plaques from pHJOF62 and pHJOF71 upon transfection into
MeWo cells was observed after four to five days, which
corresponds with the time period required for virus recovery from
the original pHJO BAC. Remaining pBeloBAC11 elements were
detected in virus progeny recovered from two pHJOF62 and
pHJOF71 BAC clones until virus passage four or seven - and
beyond - and five or six respectively (Table 1, data not shown).
The seamless repair of ORF62 or ORF71 was confirmed in
amplified PCR fragments from the repeat regions of each of the
vector-free progenies generated from the different BAC variants
(Table 1, data not shown).
Virus reconstitution by the generation of the VZV-typical
plaques was also observed after four to five days upon transfection
of MeWo cells with pHJOFpac. In the derived progeny, the vector
elements were only traceable until virus passage two (Fig. 3B). This
observation could be confirmed by eight independent transfection
experiments (Table 1). Thus, the pHJOFpac construct appeared to
be the ideal candidate to rapidly generate vector-free recombinant
progeny. Therefore, the pHJOFpac-derived virus was analyzed
in detail.
Due to nucleotide polymorphisms at the VZV DNA ends, PCR
products amplified from the terminal junction of pHJOFpac-
derived mini-F sequence-free virus rHJOpac-F
- as well as from
wild-type virus as a positive control were first cloned and then
sequenced to determine the seamless mini-F vector excision. The
repair of the terminal junction was confirmed in 16 cloned PCR
fragments derived from rHJOpac-F
- (Fig. 4). A variability of the
number of the GC base pairs (ranging from 3–8) at the junction
was detected in DNA of rHJOpac-F
- and HJO wild-type virus
(Fig. 4).
Subsequently, the genome of rHJOpac-F
- was investigated via
Southern-blot analysis, at the terminal junction, for complete
integrity, and for the absence of any pBeloBAC11 sequences. The
restriction fragment patterns were confirmed to be indistinguish-
able from that of wild-type HJO DNA and pBeloBAC11
sequences were only detected in pHJO, pHJOFep and pHJOFpac
BAC DNA, whereas not in the viral DNA (Fig. 3C). Finally,
the replication kinetics of rHJOpac-F
- upon propagation in
MeWo cells was determined. The obtained growth curve of the
recombinant virus was comparable to that of wild-type virus HJO
(Fig. 3D). Thus, pHJOFpac enables the rapid generation of
recombinant progeny that has genome and growth properties
virtually identical to the parental HJO virus. In conclusion, the
mini-F sequences were seamlessly released from the genomic
termini by intrinsic features of the VZV DNA replication process
and, in addition, the integrity of the complete HJO genome was
conserved during the entire BAC cloning and mini-F transposition
procedure in E. coli.
Discussion
In this work, we demonstrated that the low-copy F-factor
sequences can be targeted and seamlessly transposed within BAC-
cloned DNA in E. coli via Red recombination. We also
demonstrated that the mini-F vector of an infectious herpesvirus
BAC can be efficiently and seamlessly released from the genomic
termini upon virus reconstitution in eukaryotic cells by inherent
genome replication or maturation processes.
By en passant mutagenesis [11,15], it was possible to induce the
vector insertion into a target position of interest and the vector
removal from the present integration site via two synchronous Red
recombinations combined with an interposed I-SceI-mediated
double-strand break (Fig. 1C). The versatility and efficiency of the
developed transposition technique was proved by shifting the mini-
F vector into different unique and repeated regions distributed
over a cloned herpesvirus genome, finally resulting in six BAC
variants (Fig. 2 and S1). It appears therefore that the mini-F
transposition reaction enables the rapid generation of virtually
every specific variant of an established BAC in E. coli under perfect
preservation of the integrity of the cloned DNA. In the context of
the recently introduced highly versatile and markerless recombi-
neering techniques [9–12,15], this method eliminates the last
hurdle to perform virtually any kinds of imaginable targeted BAC
modifications. The mini-F transposition reaction can be therefore
generally a valuable tool to optimize, reorganize, or repair other
established BACs as well, which may have an immediate impact
on the development of gene therapy or vaccine vectors [3,6,8].
Also BACs generated by random cloning techniques could be
adapted subsequently by transposition of the mini-F vector to a
defined position to tweak those clones for further work [45]. In
addition this may be also useful to facilitate the generation of
optimized targeting vectors for mutant animals, such as condi-
tional knock-out mice [2,4,5,7].
ThetargetedgenerationofaninfectiousherpesvirusBACincludes
recombination during the virus propagation in eukaryotic cells and
transfer of circular replication intermediates into E. coli [16,29].
Therefore, it is difficult to integrate the mini-F vector into repeated
regions with self-repair potential or into sites involved in the viral
genome replication or maturation process. Using the mini-F
transposition method, we developed the first herpesvirus BACs
(Fig. 2), of which the vector sequences were efficiently released by
intrinsic features during the genome maturation process, thus,
without the need of additional sequences, such as loxP sites or a
genomic duplication [27–29]. We identified the herpesviral terminal
genomic junction as an optimal mini-F vector integration site for the
construction of an infectious BAC that provides the rapid and
spontaneous generation of recombinant progeny that is indistin-
guishable to the wild-type virus in vitro (Fig. 3 and 4). This strategy to
generate mutant herpesvirus progeny does not only avoid the
remaining ofany vector sequencesintheviral genomeitalsoreduces
the risk of illegitimate events of homologous recombination of the
chimeric DNA during the bacterial or viral DNA replication. The
terminal genomic junction might therefore be in general an optimal
integration site of the mini-F sequences to construct large linear
DNA genomes as infectious herpesvirus BACs.
The delayed virus reconstitution from the three pHJO-DX
variants (Fig. S1) may correspond with the time period required
for the mini-F excision to repair ORF22, ORF50,o rORF54 by
homologous recombination of the genomic duplications [29].
However, despite of the introduction of a highly detrimental effect
on the virus replication by the mini-F sequences within the ORFs,
it was unexpected that remaining pBeloBAC11 sequences were
detected in three further passages after virus reconstitution (data
not shown). This phenomenon may be explained by the highly
cell-associated growth of VZV, which may cause an intimate
polyclonal virus spread from cell to cell and, thus, allow the
propagation of remaining pBeloBAC11 sequences upon trans-
complementation [23,46,47]. In conclusion, the three BACs,
pHJOF22-DX, pHJOF50-DX, and pHJOF54-DX (Fig. S1), allow
the efficient and seamless vector release upon virus reconstitution,
but appear to be suboptimal for further mutant generation,
because the virus reconstitution occurs at delayed kinetics.
The vector release in virus recovered from pHJOF62 or
pHJOF71 (Fig. 2) may indicate that ORF62 or ORF71 of the large
S repeats were efficiently repaired by inherent homologous
recombination events during the viral DNA replication (Fig. S3)
[41]. To exclude any illegitimate recombination upon the vector
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PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8178Figure 3. Mini-F sequence transposition into the genomic terminal junction and release upon virus reconstitution. A) Detailed
overview of the genomic transitions in pHJOFpac and rHJOpac-F
-. The vector sequences (green) were released upon virus reconstitution from
pHJOFpac and vector-free progeny rHJOpac-F
- was generated. Lengths of both transitional SalI fragments and the distances from the SalI restriction
sites to the genomic junctions are given (black dotted lines). Also, the binding sites of the Southern-blot probe (red bars) for analyzing the terminal
junction and of the primers P1 and P2 (Table S1) used to generate the probe are indicated. B) PCR analysis of the mini-F sequence release upon virus
reconstitution. Total DNA from MeWo cells infected with pHJOFpac-derived progeny of virus passage 1–3 was analyzed with the cat-specific primers
P3 and P4 (Table S1). BAC DNA of original pHJO as well as total DNA from MeWo cells infected with HJO wild-type or uninfected cells were analyzed
as controls. C) Southern-blot analysis of pHJOFpac and rHJOpac-F
- in comparison to HJO, pHJO, pHJOFep. BAC DNA was prepared from E. coli
harboring pHJO, pHJOFep, or pHJOFpac. Total DNA from MeWo cells infected with HJO or rHJOpac-F
- was purified for examination of virus DNA. The
isolated DNA was digested with SalI, separated electrophoretically on a 1% agarose gel, and blotted. Genomic junction-, vector-, or VZV sequences
were detected with probes specific for viral sequences spanning the genomic transition at the ORF0 end of the UL region (termed S/L0, red bars in A),
the pBeloBAC11 plasmid, or pHJO DNA, respectively. The 3 kb or 6 kb SalI fragments corresponding to the terminal or internal junction as well as the
9.5 kb SalI fragments that correspond to the terminal junction with mini-F vector in pHJOFpac as presented in A are marked. Also indicated are the
1.6 kb and 1.4 kb SalI fragments that correspond to termini of linear genomes within viral DNA as outlined in A as well as the 2.6 kb SalI fragments
that correspond to the restored US unique AvrII site (arrows flanking the picture frame). D) Growth kinetics of rHJOpac-F
- and HJO. Multistep growth
kinetics of rHJOpac-F
- compared to wild-type virus HJO in MeWo cell cultures was performed. Means and standard deviations of two independent
experiments with three separate results each are given.
doi:10.1371/journal.pone.0008178.g003
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the derived viruses had to be analyzed for instance by Southern-
blot hybridization. Nevertheless, the BAC variants allowed the
virus reconstitution in eukaryotic cells and the vector elements
were released upon propagation of the recombinant progeny,
accepting them as valuable alternatives to generate vector-free
mutant VZV.
The observation that the mini-F sequences in progeny
reconstituted from pHJOFpac were much more efficiently released
in comparison to that of the other generated recombinant viruses
(Table 1), may support the proposal that the vector sequences can
be actively excised from the genomic termini. This conclusion
would then greatly support the assumption that the formation of
the herpesvirus genomic termini is to some degree independently
governed from the respective packaging signals [42–44]. Besides
such an active cleavage mechanism, the mini-F vector excision
from the genomic terminal junction may also be effectuated by
highly frequent homologous recombination of the viral repeat
elements, supported by a different double-strand break mechanism
or by a high GC content [35,37]. However, the VZV L repeats are
only 88 bp in length [30], which makes an efficient intrinsic vector
release unlikely that happens just by homologous recombination of
the RL and RS regions flanking the mini-F cassette with the RL
and RS regions of the intact junction (Fig. 3A).
The pHJOpac clone enables the rapid generation of virus
progeny that is virtually identical in its genome and replication
kinetics to wild-type virus HJO. This BAC variant has already
been used successfully in bacteria to introduce further targeted
mutations into the cloned viral genome and to derive vector-free
VZV mutants in eukaryotic cell culture (Krater T, Brunnemann
A, and Fickenscher H, unpublished). In conclusion, pHJOFpac is
an ideal construct for the rapid production of VZV mutants
without the retention of any unwanted operational sequences in
the manipulated viral genome.
In summary, we have developed a method for the targeted and
seamless restructuring of an established BAC in E. coli. Using this
tool, we finally engineered a herpesvirus BAC with mini-F sequences
between the genomic termini, which allows the rapid production of
recombinant virus virtually identical to the wild-type.
Materials and Methods
Construction of the Transfer Vectors
To remove loxP and cos sequences and to introduce a BamHI or
SphI site, pBeloBAC11 (Invitrogen, Karlsruhe, Germany) was
digested with SalI and the released 6.4 kb fragment was ligated
with the XhoI-treated hybrid of the oligonucleotides A and B or C
and D (Table S1), to yield pBeloBamHI or pBeloSphI, respectively.
For the mini-F sequence transfer into ORF22, ORF50, ORF54,
or ORF62/71, viral sequences were amplified with primers E and
F, G and H, I and J or K and L (Table S1), and the 1.4 kb PCR
products were inserted after SpeI digestion into the XbaI site of
plasmid pCeu2 [29]. To generate a BamHI site for mini-F
sequence transfer into the terminal junction, 0.7 kb PCR-
fragments amplified from both genomic ends using primers M
and N or O and P (Table S1), were digested with SalI or SpeI and
successively inserted into the XhoI or XbaI site of pCeu2.
Subsequently, the mini-F plasmid pBeloSphI was inserted into the
SphI site of the cloned fragments of ORF22 and ORF54, and
pBeloBamHI was ligated into the BamHI site of the cloned
fragments of ORF50, ORF62/71 (in forward and reverse
orientation) or the cloned genomic terminal transition. Hence,
six different pBelo-HJO-in transfer plasmids were generated.
Transfer constructs for the insertion of a genomic duplication
into the pBeloBAC11 sequences within ORF22, ORF50,o rORF54
were generated by using the primers E and F, G and H or I and J.
The SpeI-digested PCR products were inserted into the BlnI site of
the plasmid pEPMCS-in-Belo [29], resulting in three different
pEP-HJO-DX-in plasmids.
Red Recombination
Red-mediated modification of BAC DNA was performed as
described using the E. coli strain GS1783, which contains a
temperature-dependent expression cassette for the recombination
proteins and an L-(+)-arabinose-inducible I-sceI gene [11,14,15].
PCR products used for en passant mutagenesis were generated with
polyacrylamide-gel electrophoresis-purified primers (Biomers, Ulm,
Germany).
In the novel transposition reaction, E. coli GS1783 harboring
pHJOFep (Fig. 1B) were grown in the presence of kanamycin and
prepared for Red recombination and electroporated as described
before [11,14]. Approximately 100–300 ng of a 7.8 kb mini-F
transfer construct derived by I-CeuI-digestion of a corresponding
pBelo-HJO-in plasmid were introduced by electroporation into
GS1783 to insert the 6.4 kb pBeloBAC11 derivate via the 0.7 kb
homologous sequences into the target position of interest in
pHJOFep (Fig. 1C). Afterwards, the bacteria were resuspended in
1 ml LB medium without antibiotics and grown for 2 h at 32uC.
The second en passant step was induced to immediately remove
the pre-existing pBeloBAC11 vector, simultaneously maintaining
Figure 4. Sequence analysis after mini-F vector release from the genomic termini. Sequence analysis of 16 cloned PCR fragments that were
generated by PCR amplification of the terminal genomic junction of rHJOpac-F
- or wild-type HJO DNA. The derived sequences were aligned to the
sequence of the terminal transition of the original pHJO clone (first line). The GC tracts directly at the junction are highlighted in gray.
doi:10.1371/journal.pone.0008178.g004
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Therefore, 1 ml pre-warmed LB medium with 60 mg/ml chloram-
phenicol and 1% arabinose was added to the suspension to select for
catco-integratesandto inducesimultaneouslya double-strandbreak
at the I-SceI site adjacent to the aphAI-associated pBeloBAC11
mini-F cassette (Fig. 1C). Bacteria were grown for an additional
hour at 32uC until shifted for 30 min to 42uC to express the Red
proteins again, enabling the excision of the aphAI-associated
pBeloBAC11 cassette by recombination of the flanking 50 bp viral
sequence duplication (Fig. 1C). Finally, the suspension was grown
for 2 h at 32uC and bacteria were selected at 32uC on agar plates
containing 30 mg/ml chloramphenicol and 1% arabinose.
Generation of the BAC Constructs
To generate pHJOFep,a naphAI-I-SceI cassette from pEPkan-S
[11] was amplified with the primers Q and R (Table S1), which
provide a 50 bp viral sequence duplication, and the PCR product
was used to replace cat from pHJO via Red recombination (Fig. 1B).
For the generation of the different pHJO variants, the pBelo-HJO-in
transfer constructs were digested with I-CeuI and the obtained 7.8 kb
fragments were used in the transposition reaction (Fig. 1) to insert
6.4 kb pBeloBAC11 sequences into a novel position and to release
the mini-F vector sequences of pHJOFep, resulting in pHJOF22,
pHJOF50, pHJOF54, pHJOF62, pHJOF71, or pHJOFpac (Fig. 2
and S1).
The genomic duplications were inserted into pHJOF22,
pHJOF50, or pHJOF54 as described previously [29]. The
corresponding transfer plasmid pEP-HJO-DX-in was digested
with I-CeuI and the release 4.2 kb fragments were used in an en
passant procedure to insert the viral sequence duplications in
reverse orientation into the mini-F vector, resulting in pHJOF22-
DX, pHJOF50-DX, or pHJOF54-DX (Fig. S1).
Virus Cultivation
Viruses were propagated in permissive MeWo melanoma cells
grown in Dulbecco’s Minimal Essential Medium (DMEM) containing
10% heat-inactivated fetal bovine serum, penicillin, and streptomy-
cin (PAA, Co ¨lbe, Germany). Virus was passaged by co-cultivation of
infected cells with uninfected MeWo cells derived from confluent
monolayers to yield cultureswith a CPE of 70–80% after6 to7 days.
The complete sequence of the VZV strain HJO is available in
GenBank under accession number AJ871403.1 [24,25].
Virus Reconstitution from BAC DNA
Virus reconstitution was achieved by transfection of MeWo cells
with BAC DNA using Lipofectamine2000 (Invitrogen) according
to the manufacturer’s instructions. Transfection was performed in
6-well format with 4 mg of purified BAC DNA (Plasmid Maxi Kit,
Qiagen, Hilden, Germany). DNA-lipofectamine complexes were
added to the cells in DMEM without L-glutamine. Transfection
medium was replaced after 24 h with normal culture medium.
Southern-Blot Hybridization
Southern-blot hybridization was performed using the DIG High
Prime DNA Labelling and Detection Starter Kit II (Roche,
Mannheim, Germany) according to manufacturer’s instructions.
Probes specific for pHJO or pBeloBAC11 fragments were
generated by random labelling with digoxigenin of sonicated
purified BAC DNA. The probe specific for the terminal transition
was derived from PCR products generated with primers P1 and P2
(Fig. 3A and Table S1) using HJO DNA as template. For
analyzing viral DNA, total DNA of infected MeWo cells from
cultures with CPE of 70–80% cells was purified with the DNeasy
Blood & Tissue Kit (Qiagen) according to the manufacturer’s
recommendations. BAC DNA was prepared from E. coli by
alkaline lysis. Viral DNA (approximately 10 mg) and BAC DNA
(1–2 mg) was digested with restriction endonucleases, separated on
a 1% agarose gel and blotted to a positively charged nylon
membrane. Hybridizations were finally visualized by chemilumi-
nescence detection using the LAS-3000 imaging system (Fuji,
Tokyo, Japan)
Multistep Virus Replication Kinetics
Replication kinetics of rHJOpac-F
- and HJO wild-type virus were
determined as follows. First, 1610
6 MeWo cells were seeded in 6-
well plates and inoculated after 24 h with 100 plaque- forming units
of titrated and frozen cell-associated virus. Cells of three wells each
were trypsinized on day 1 to 5 and separately titrated in
quadruplicates by co-cultivation of serial 10-fold dilutions of the
harvested inocula with subconfluent uninfected MeWo cells (2610
5
cells) seeded in 24-well plates the day before. Viral plaques were
stained 3 days after infection by indirect immunofluorescence using
a monoclonal antibody against glycoprotein I (anti-VZV-gI,
Millipore, Schwalbach, Germany) and counted using the Olympus
microscope IX81. The entire experiment was performed twice and
growth curves were established by the average of 6 parallel results
for each time point.
Immunofluorescence
Cells were fixed with 2% paraformaldehyde inphosphate-buffered
saline (PBS), permeabi-lized with 0.1% saponin in PBS, and blocked
with 10% fetal bovine serum (FBS) in PBS. Cellswere incubated with
the primary antibody monoclonal anti-VZV-gI diluted 1:500 in PBS
containing 10% FBS and 0.02% sodium azide and subsequently with
the secondary Alexa 488-conjugated goat anti-mouse antibody
(Invitrogen) diluted 1:1,000 in PBS with 10% FBS. Fluorescence
was visualized with an Olympus IX81 microscope.
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